Skip To Main Content
Anamaria Daniela Sarca on Muck Rack

Anamaria Daniela Sarca

As seen in: Journal of Virology
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work. Claim your profile

Get in touch with Anamaria Daniela

Contact Anamaria Daniela, search articles and posts on X, monitor coverage, and track replies from one place.

Learn more about Muck Rack

Actions

Share this page

Is this you?

As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile

Articles

CAGE-Seq Reveals that HIV-1 Latent Infection Does Not Trigger Unique Cellular Responses in a Jurkat T Cell Model

|
By Anamaria Daniela Sarca, Emilie Battivelli, Eric Verdin, Frank Kirchhoff
| Journal of Virology Verified
Cellular Response to Infection Hiroyuki Matsui, Kotaro Shirakawa, Yoshinobu Konishi, Shigeki Hirabayashi, Anamaria Daniela Sarca, Hirofumi Fukuda, Ryosuke Nomura, Emani Stanford, Yoshihito Horisawa, Yasuhiro Kazuma, Tadahiko Matsumoto, Hiroyuki Yamazaki, Yasuhiro Murakawa, Emilie Battivelli, Eric Verdin, Yoshio Koyanagi, Akifumi Takaori-Kondo Frank Kirchhoff, Editor DOI: 10.1128/JVI.02394-20 ABSTRACT The cure for HIV-1 is currently stalled by our inability to specifically identify and target...
Open in Who Shared Issue with article?

CAGE-seq reveals that HIV-1 latent infection does not trigger unique cellular responses in a Jurkat T cell model.

|
By Emilie Battivelli, Eric Verdin, Anamaria Daniela Sarca
| Journal of Virology Verified
Cellular Response to Infection Hiroyuki Matsui, Kotaro Shirakawa, Yoshinobu Konishi, Shigeki Hirabayashi, Anamaria Daniela Sarca, Hirofumi Fukuda, Ryosuke Nomura, Emani Stanford, Yoshihito Horisawa, Yasuhiro Kazuma, Tadahiko Matsumoto, Hiroyuki Yamazaki, Yasuhiro Murakawa, Emilie Battivelli, Eric Verdin, Yoshio Koyanagi, Akifumi Takaori-Kondo DOI: 10.1128/JVI.02394-20 ABSTRACT The cure for HIV-1 is currently stalled by our inability to specifically identify and target latently infected cells.
Open in Who Shared Issue with article?
See all 2 articles